X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

COVID-19 Grant Turned To Telehealth Service At MaineHealth

Content Team by Content Team
27th July 2022
in Health & Nutrition, News
COVID-19 Grant Turned To Telehealth Service At MaineHealth

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Similar to several other health systems around the nation, COVID-19 forced MaineHealth to act quickly to care for patients remotely in order to protect both individuals and care teams.

The Issue

According to Lizzy Mulcahy, director of telehealth at the Portland, Maine-based health system, this was pertinent to patient populations in the outpatient program, who needed to be kept connected with their primary care and specialist providers for acute or chronic needs, including for patient populations in the inpatient unit, who were able to receive some of their care virtually.

MaineHealth integrated virtual care services into its care ecosystem to address the need to deliver care virtually, which required recognising and buying the software and hardware solutions, implementing significant patient and care team education initiatives, and creating a process for quality control and analytics, the spokesperson said.

Proposal

MaineHealth sought telemedicine technologies that would be simple to incorporate into its care delivery models and that patients would have easy access to.

IT director for client services and telehealth at MaineHealth, Patty VonIderstine, stated that the solution needs to be able to work efficiently in low-bandwidth areas due to the rurality of Maine. To avoid escalating the hurdles to digital access and digital literacy, selecting a solution that was simple to use for both patients and the care teams was of utmost importance.

Conquering The Trouble

Both inpatient and outpatient settings have employed the telemedicine technology MaineHealth chose. According to telehealth technical architect at MaineHealth, Tom Winchell, in the hospital setting, Vidyo was used to digitally connect care teams with patients in isolation areas. Zoom service access was launched and widely implemented for direct patient care in the outpatient context.

In a fairly short amount of time, around 1,000 licences were implemented, he added. The Zoom capabilities were used for direct patient care among doctors, whether in an office setting or at a distance, with patients who were placed in their own homes and eventually integrated into MaineHealth’s HER.

MaineHealth also bought care team setups, such as desktop PCs, iPads, and web cameras, in order to take part in virtual care.

Results

Utilization has so far been the main success statistic linked to the application of this technology, according to VonIderstine. Care team adoption was widespread; primary care, specialised care, and behavioural health services all had high utilisation rates.

They are still seeing significant amounts of utilisation, especially in the behavioural health sector, she continued. Now that things are moving across to the other side of the pandemic, additionally, group sessions for managing chronic diseases or changing behaviour around a healthy lifestyle have been considered as having a high value for the virtual services.

Using FCC Award Funds

MaineHealth received $803,268 from the FCC telehealth award programme for telemedicine carts, laptops, tablets, and videoconferencing equipment and software that will enable providers to conduct virtual rounds for inpatients, allow patients to see specialised care and primary care providers from the comfort of their own homes, and enable patients in hospitals to use tablets to see and interact with family members they otherwise would be unable to see due to prolonged bed rest.

The FCC CARES program’s resources, according to VonIderstine, enabled a swift rollout of new work processes, modalities, and structure for the delivery of healthcare for the patients of MaineHealth. MaineHealth patients now have access to a strong, comprehensive, and active virtual care option that was not available before the pandemic.

She said, this was planned, bought, tested, deployed, and triggered in a coordinated timetable. The COVID response build-out’s initial phase was able to proceed with better effectiveness and efficiency thanks to CARES’ financial support than would have been otherwise possible. Now that the framework for virtual care has been built, MaineHealth anticipates continuing to expand its omni-channel options for patients and care teams in order to increase the standard of care, enhance the patient experience, and enhance the experience of the care team, she said.

Previous Post

Merck and Orion Announce Global Collaboration for Oncology Drug

Next Post

Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer

Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In